Hepatocellular carcinoma and cancer-related mortality after kidney transplantation with rituximab treatment.
Hayoung LeeYoung Hoon KimSeong Jun LimYoungmin KoSung ShinJoo Hee JungChung Hee BaekHyo Sang KimSu-Kil ParkHyunwook KwonPublished in: Annals of surgical treatment and research (2022)
Our results suggest that single-dose rituximab for desensitization may not increase the risk of malignant disease or cancer-related mortality in KT recipients. HCC was associated with the highest risk of cancer-related mortality in an endemic area of HBV infection.